Form D — Merge Bio Therapeutics Corp
0001231919-25-000205 · filed 2025-09-17
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $14,999,979
- Total sold
- $4,999,998
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Merge Bio Therapeutics Corp
- CIK
- 2086124
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 1 KENDALL SQUARE, BUILDING 200
CAMBRIDGE, MA 02139 - Phone
- 617-286-2631
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Wesley Wong · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Steve Liapis · DirectorCambridge, MA Find on LinkedIn ↗
-
Elias Quijano · DirectorCambridge, MA Find on LinkedIn ↗
-
Clinton Hansen · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Mark Lipstein · PromoterCambridge, MA Find on LinkedIn ↗
-
Darren Yang · PromoterCambridge, MA Find on LinkedIn ↗
View original on SEC EDGAR.